Pharmaceutical | PLS | GA-PLS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Conc (μg/mL) | PLS found (μg/mL) | GA-PLS found (μg/mL) | FPV | CEF | MFX | FPV | CEF | MFX | ||||||
Pure added (μg/mL) | % R* | Pure added (μg/mL) | % R* | Pure added (μg/mL) | % R* | Pure added (μg/mL) | % R* | Pure added (μg/mL) | % R* | Pure added (μg/mL) | % R* | |||
FPV (3) | (3.04)* | (3.02)* | 3 | 97.67 | 3 | 100.33 | 3 | 99.33 | 3 | 101.33 | 3 | 99.33 | 3 | 98.67 |
CEF (3) | (3.07)* | (2.95)* | 3.5 | 101.71 | 3.5 | 98.86 | 3.5 | 102.29 | 3.5 | 99.14 | 3.5 | 98.29 | 3.5 | 101.14 |
MFX (3) | (2.95)* | (3.03)* | 4 | 98.75 | 4 | 101.75 | 4 | 101.50 | 4 | 100.75 | 4 | 99.25 | 4 | 99.50 |
Mean | Â | 99.38 | Â | 100.31 | Â | 101.04 | Â | 100.41 | Â | 98.96 | Â | 99.77 | ||
%RSD | Â | 2.109 | Â | 1.442 | Â | 1.513 | Â | 1.130 | Â | 0.588 | Â | 1.263 |